Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.

作者: Yajun Deng , Qiqi Xie , Guangzhi Zhang , Shaoping Li , Zuolong Wu

DOI: 10.3892/OL.2019.11044

关键词:

摘要: Ewing's sarcoma (ES) is a common malignant bone tumor in children and adolescents. Although great efforts have been made to understand the pathogenesis development of ES, underlying molecular mechanism remains unclear. The present study aimed identify new key genes as potential biomarkers for diagnosis, targeted therapy or prognosis ES. mRNA expression profile chip data sets GSE17674, GSE17679 GSE45544 were downloaded from Gene Expression Omnibus database. Differentially expressed (DEGs) screened using R software limma package, functional pathway enrichment analyses performed enrichplot package GSEA software. NetworkAnalyst online tool, well Cytoscape its plug-ins cytoHubba NetworkAnalyzer, used construct protein-protein interaction network (PPI) conduct module analysis screen (hub) genes. LABSO COX regression overall survival (OS) Hub performed. A total 211 DEGs obtained by integrating analyzing three sets. functions pathways mainly associated with regulation small-molecule metabolic processes, cofactor-binding, amino acid, proteasome ribosome biosynthesis eukaryotes, Rac1, cell cycle P53 signaling pathways. one important 20 hub PPI Maximum Correlation Criteria algorithm cytoHubba. LASSO results revealed that titin (TTN), fast skeletal muscle troponin T, actin α-actin, nebulin, C type 2 (fast), myosin light-chain 3 (MYL3), slow T (TNNT1), myosin-binding protein C1 slow-type, tropomyosin heavy-chain 7 patients Kaplan-Meier curves demonstrated high levels TNNT1 (P<0.001), TTN (P=0.049), titin-cap (P=0.04), tropomodulin 1 (P=0.011), I2 (P=0.021) MYL3 (P=0.017) poor OS In conclusion, identified may be which, namely TNNT1, MYL3, prognostic

参考文章(85)
Dedík L, Durisová M, SURVIVAL--an integrated software package for survival curve estimation and statistical comparison of survival rates of two groups of patients or experimental animals. Methods and Findings in Experimental and Clinical Pharmacology. ,vol. 15, pp. 535- 540 ,(1993)
Shinya Kawabe, Tetsuya Mizutani, Shin Ishikane, Miguel Ernesto Martinez, Yasushi Kiyono, Koichi Miura, Hiroshi Hosoda, Yoshitaka Imamichi, Kenji Kangawa, Kaoru Miyamoto, Yoshio Yoshida, Establishment and characterization of a novel orthotopic mouse model for human uterine sarcoma with different metastatic potentials. Cancer Letters. ,vol. 366, pp. 182- 190 ,(2015) , 10.1016/J.CANLET.2015.06.018
Kate Lawrenson, Elham Pakzamir, Biao Liu, Janet M. Lee, Melissa K. Delgado, Kara Duncan, Simon A. Gayther, Song Liu, Lynda Roman, Paulette Mhawech-Fauceglia, Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium PLOS ONE. ,vol. 10, pp. e0130909- ,(2015) , 10.1371/JOURNAL.PONE.0130909
Ayako Haga, Yoko Ogawara, Daisuke Kubota, Issay Kitabayashi, Yasufumi Murakami, Tadashi Kondo, Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma. Electrophoresis. ,vol. 34, pp. 1670- 1678 ,(2013) , 10.1002/ELPS.201200661
Xing Gu, Bin Li, Mingming Jiang, Meng Fang, Jun Ji, Aihua Wang, Mengmeng Wang, Xiaoqing Jiang, Chunfang Gao, RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma Oncotarget. ,vol. 6, pp. 20661- 20671 ,(2015) , 10.18632/ONCOTARGET.3861
Daniel M. Lerman, Michael J. Monument, Elizabeth McIlvaine, Xiao-qiong Liu, Dali Huang, Laura Monovich, Natalie Beeler, Richard G. Gorlick, Neyssa M. Marina, Richard B. Womer, Julia A. Bridge, Mark D. Krailo, R. Lor Randall, Stephen L. Lessnick, , Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. ,vol. 62, pp. 759- 765 ,(2015) , 10.1002/PBC.25340
Sophie Postel-Vinay, Amélie S Véron, Franck Tirode, Gaelle Pierron, Stéphanie Reynaud, Heinrich Kovar, Odile Oberlin, Eve Lapouble, Stelly Ballet, Carlo Lucchesi, Udo Kontny, Anna González-Neira, Piero Picci, Javier Alonso, Ana Patino-Garcia, Brigitte Bressac de Paillerets, Karine Laud, Christian Dina, Philippe Froguel, Françoise Clavel-Chapelon, Francois Doz, Jean Michon, Stephen J Chanock, Gilles Thomas, David G Cox, Olivier Delattre, Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma Nature Genetics. ,vol. 44, pp. 323- 327 ,(2012) , 10.1038/NG.1085
Katia Scotlandi, Sofia Avnet, Stefania Benini, Maria Cristina Manara, Massimo Serra, Vanessa Cerisano, Stefania Perdichizzi, Pier-Luigi Lollini, Carla De Giovanni, Lorena Landuzzi, Piero Picci, Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells. International Journal of Cancer. ,vol. 101, pp. 11- 16 ,(2002) , 10.1002/IJC.10537
Nayoung Kim, Yourae Hong, Doyoung Kwon, Sukjoon Yoon, Somatic Mutaome Profile in Human Cancer Tissues Genomics & Informatics. ,vol. 11, pp. 239- 244 ,(2013) , 10.5808/GI.2013.11.4.239
D Herrero-Martín, D Osuna, J L Ordóñez, V Sevillano, A S Martins, C Mackintosh, M Campos, J Madoz-Gúrpide, A P Otero-Motta, G Caballero, A T Amaral, D H Wai, Y Braun, M Eisenacher, K-L Schaefer, C Poremba, E de Alava, Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target British Journal of Cancer. ,vol. 101, pp. 80- 90 ,(2009) , 10.1038/SJ.BJC.6605104